Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for erectile dysfunction after COVID-19
IRCT20170807035551N2Phase 3Completed
- Sponsor
- Urology Research Center
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in erectile dysfunction (ED) comparing Tadalafil with Placebo (2 arms). Primary endpoint: Severity of erectile dysfunction. Started Jan 2021; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on IRCT20170807035551N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170807035551N2.